Skip to content

An exploratory study on the improvement effect of continuous intake of test food on anemia-related biomarkers. -a open-label, parallel-group comparison trial-

An exploratory study on the improvement effect of continuous intake of test food on anemia-related biomarkers. -a open-label, parallel-group comparison trial- - An exploratory study on the improvement effect of continuous intake of test food on anemia-related biomarkers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047002
Enrollment
50
Registered
2022-02-25
Start date
2022-03-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take the test food alone before or after breakfast. No treatment.

Sponsors

IMEQRD Co, Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 20 and less than 59. 2. Japanese females. 3. Normal menstrual periods. 4. Have awareness of anemia 5. Can use smartphones or PCs to input an electronic diary. 6. Received sufficient explanation for the objective and summary of the study, and voluntarily volunteered to the study with the agreement of informed consent.

Exclusion criteria

Exclusion criteria: 1. Currently undergoing treatment for any disease, or receive medical treatment such as medical drugs or traditional Chinese medicines. 2. Receiving nutritional and exercise therapy under medical doctors. 3. Have severe diseases or a history of severe diseases. 4. Have been received GI tract surgery (except for appendicitis). 5. Have currently been taking commercially available drugs, quasi-drug products, foods, or supplements with any functional claims. However, can discontinue taking these drugs/foods during the trial period is acceptable to join the study. 6. Have an allergy to drugs, or foods. 7. Planning extremely change lifestyle (such as diet, sleep, or exercise) during the study period. 8. Work in shift and night shift. 9. Planning travel to foreign countries during the study period. 10. Currently pregnant or breastfeeding, or planning to pregnant during the study period. 11. Take more than 60 g alcohol/day. 12. Smoker (more than 21 cigarettes/day). 13. Donated blood (including plasma or serum) more than 200 mL within three months before the study. 14. Individuals who joined other clinical trials from one month before the trial, individuals who have currently been joined other clinical trials, and also individuals who are planning to join other clinical trials during the trial. 15. Unsuitable for this study, that judged by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Blood hemoglobin levels, RBC counts, hematocrit levels, blood transferrin levels, UIBC, TIBC, serum Fe, reticulocyte counts, blood ferritin levels Blood erythropoietin kinetics after the single intake of the test food

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co, Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp0367045968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026